Umb Bank, N.A. Astrazeneca PLC Transaction History
Umb Bank, N.A.
- $6.26 Billion
- Q2 2025
A detailed history of Umb Bank, N.A. transactions in Astrazeneca PLC stock. As of the latest transaction made, Umb Bank, N.A. holds 14,988 shares of AZN stock, worth $1.26 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,988
Previous 16,016
6.42%
Holding current value
$1.26 Million
Previous $1.12 Million
6.43%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.36 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...